ARWR logo

ARWR Net income

annual net income:

-$609.69M-$400.42M(-191.34%)
September 30, 2024

Summary

  • As of today (September 10, 2025), ARWR annual net profit is -$609.69 million, with the most recent change of -$400.42 million (-191.34%) on September 30, 2024.
  • During the last 3 years, ARWR annual net income has fallen by -$468.85 million (-332.87%).
  • ARWR annual net income is now -996.94% below its all-time high of $67.97 million, reached on September 30, 2019.

Performance

ARWR Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRincome statement metrics

quarterly net income:

-$178.65M-$546.51M(-148.56%)
June 30, 2025

Summary

  • As of today (September 10, 2025), ARWR quarterly net profit is -$178.65 million, with the most recent change of -$546.51 million (-148.56%) on June 30, 2025.
  • Over the past year, ARWR quarterly net income has dropped by -$4.67 million (-2.69%).
  • ARWR quarterly net income is now -148.56% below its all-time high of $367.86 million, reached on March 31, 2025.

Performance

ARWR quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRincome statement metrics

TTM net income:

-$159.35M-$4.67M(-3.02%)
June 30, 2025

Summary

  • As of today (September 10, 2025), ARWR TTM net profit is -$159.35 million, with the most recent change of -$4.67 million (-3.02%) on June 30, 2025.
  • Over the past year, ARWR TTM net income has increased by +$388.01 million (+70.89%).
  • ARWR TTM net income is now -334.43% below its all-time high of $67.97 million, reached on September 30, 2019.

Performance

ARWR TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

ARWR Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-191.3%-2.7%+70.9%
3 y3 years-332.9%-148.0%-3.5%
5 y5 years-996.9%-1212.5%-552.7%

ARWR Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-332.9%at low-148.6%at low-4.8%+75.5%
5 y5-year-996.9%at low-148.6%at low-552.7%+75.5%
alltimeall time-996.9%at low-148.6%at low-334.4%+75.5%

ARWR Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$178.65M(-148.6%)
-$159.35M(+3.0%)
Mar 2025
-
$367.86M(-309.9%)
-$154.68M(-76.2%)
Dec 2024
-
-$175.22M(+1.1%)
-$649.53M(+6.5%)
Sep 2024
-$609.69M(+191.3%)
-$173.34M(-0.4%)
-$609.69M(+11.4%)
Jun 2024
-
-$173.98M(+37.0%)
-$547.36M(+14.6%)
Mar 2024
-
-$127.00M(-6.2%)
-$477.51M(+57.7%)
Dec 2023
-
-$135.38M(+21.9%)
-$302.84M(+44.7%)
Sep 2023
-$209.28M(+18.6%)
-$111.02M(+6.6%)
-$209.28M(+13.6%)
Jun 2023
-
-$104.13M(-318.4%)
-$184.20M(+21.1%)
Mar 2023
-
$47.68M(-214.0%)
-$152.12M(-2.1%)
Dec 2022
-
-$41.81M(-51.3%)
-$155.43M(-11.9%)
Sep 2022
-$176.49M(+25.3%)
-$85.94M(+19.3%)
-$176.49M(+14.7%)
Jun 2022
-
-$72.05M(-262.4%)
-$153.93M(+37.7%)
Mar 2022
-
$44.37M(-170.6%)
-$111.80M(-38.9%)
Dec 2021
-
-$62.87M(-0.8%)
-$182.99M(+29.9%)
Sep 2021
-$140.85M(+66.6%)
-$63.37M(+111.8%)
-$140.85M(+11.9%)
Jun 2021
-
-$29.92M(+11.6%)
-$125.91M(+14.9%)
Mar 2021
-
-$26.82M(+29.4%)
-$109.59M(+6.8%)
Dec 2020
-
-$20.73M(-57.2%)
-$102.61M(+21.4%)
Sep 2020
-$84.55M(-224.4%)
-$48.43M(+255.8%)
-$84.55M(+246.3%)
Jun 2020
-
-$13.61M(-31.4%)
-$24.42M(-356.2%)
Mar 2020
-
-$19.84M(+641.9%)
$9.53M(-82.1%)
Dec 2019
-
-$2.67M(-122.8%)
$53.26M(-21.6%)
Sep 2019
$67.97M(-224.8%)
$11.70M(-42.4%)
$67.97M(+49.4%)
Jun 2019
-
$20.34M(-14.9%)
$45.51M(+375.7%)
Mar 2019
-
$23.90M(+98.5%)
$9.57M(-132.7%)
Dec 2018
-
$12.04M(-211.9%)
-$29.21M(-46.3%)
Sep 2018
-$54.45M(+58.4%)
-$10.76M(-31.0%)
-$54.45M(+0.1%)
Jun 2018
-
-$15.61M(+4.8%)
-$54.42M(+22.8%)
Mar 2018
-
-$14.88M(+12.8%)
-$44.33M(+24.9%)
Dec 2017
-
-$13.20M(+23.0%)
-$35.49M(+3.2%)
Sep 2017
-$34.38M(-57.9%)
-$10.73M(+94.4%)
-$34.38M(-25.0%)
Jun 2017
-
-$5.52M(-8.7%)
-$45.87M(-23.3%)
Mar 2017
-
-$6.04M(-50.0%)
-$59.77M(-19.8%)
Dec 2016
-
-$12.09M(-45.6%)
-$74.54M(-8.8%)
Sep 2016
-$81.72M(-11.1%)
-$22.22M(+14.4%)
-$81.72M(-3.0%)
Jun 2016
-
-$19.42M(-6.7%)
-$84.24M(+4.3%)
Mar 2016
-
-$20.82M(+8.1%)
-$80.76M(-8.9%)
Dec 2015
-
-$19.26M(-22.1%)
-$88.63M(-3.6%)
Sep 2015
-$91.94M(+56.6%)
-$24.74M(+55.3%)
-$91.94M(+2.6%)
Jun 2015
-
-$15.94M(-44.4%)
-$89.63M(+5.1%)
Mar 2015
-
-$28.68M(+27.1%)
-$85.32M(+20.8%)
Dec 2014
-
-$22.58M(+0.6%)
-$70.61M(+20.2%)
Sep 2014
-$58.73M(+85.2%)
-$22.43M(+92.9%)
-$58.73M(+17.2%)
Jun 2014
-
-$11.63M(-16.9%)
-$50.10M(+12.2%)
Mar 2014
-
-$13.98M(+30.9%)
-$44.65M(+18.7%)
Dec 2013
-
-$10.69M(-22.6%)
-$37.61M(+18.6%)
Sep 2013
-$31.70M(+43.4%)
-$13.81M(+123.5%)
-$31.70M(+34.9%)
Jun 2013
-
-$6.18M(-11.0%)
-$23.50M(-8.1%)
Mar 2013
-
-$6.94M(+45.2%)
-$25.56M(+5.6%)
Dec 2012
-
-$4.78M(-14.6%)
-$24.20M(+9.5%)
Sep 2012
-$22.11M
-$5.60M(-32.0%)
-$22.11M(+13.6%)
Jun 2012
-
-$8.24M(+47.6%)
-$19.46M(+47.8%)
Mar 2012
-
-$5.58M(+107.8%)
-$13.16M(+59.5%)
DateAnnualQuarterlyTTM
Dec 2011
-
-$2.69M(-8.8%)
-$8.25M(+14.4%)
Sep 2011
-$8.79M(+19.0%)
-$2.95M(+51.5%)
-$7.21M(+9.3%)
Jun 2011
-
-$1.94M(+187.8%)
-$6.60M(+23.7%)
Mar 2011
-
-$675.60K(-59.0%)
-$5.33M(-14.3%)
Dec 2010
-
-$1.65M(-29.4%)
-$6.22M(-4.8%)
Sep 2010
-$7.38M(-61.8%)
-$2.33M(+243.9%)
-$6.54M(-14.7%)
Jun 2010
-
-$678.20K(-56.7%)
-$7.66M(-19.4%)
Mar 2010
-
-$1.57M(-20.1%)
-$9.51M(-28.1%)
Dec 2009
-
-$1.96M(-43.4%)
-$13.24M(-31.4%)
Sep 2009
-$19.31M(-43.8%)
-$3.46M(+36.8%)
-$19.31M(-21.2%)
Jun 2009
-
-$2.53M(-52.2%)
-$24.51M(-22.8%)
Mar 2009
-
-$5.29M(-34.1%)
-$31.76M(-4.7%)
Dec 2008
-
-$8.03M(-7.3%)
-$33.31M(+4.6%)
Sep 2008
-$34.38M(-6.3%)
-$8.66M(-11.5%)
-$31.85M(-7.5%)
Jun 2008
-
-$9.78M(+43.0%)
-$34.45M(-8.9%)
Mar 2008
-
-$6.84M(+4.1%)
-$37.82M(-3.2%)
Dec 2007
-
-$6.57M(-41.6%)
-$39.09M(+6.6%)
Sep 2007
-$36.68M(+80.6%)
-$11.26M(-14.5%)
-$36.68M(-1.2%)
Jun 2007
-
-$13.16M(+62.3%)
-$37.13M(+33.9%)
Mar 2007
-
-$8.11M(+94.9%)
-$27.72M(+25.2%)
Dec 2006
-
-$4.16M(-64.4%)
-$22.13M(+1.0%)
Sep 2006
-$20.31M(+197.1%)
-$11.70M(+211.7%)
-$21.91M(+111.2%)
Jun 2006
-
-$3.75M(+48.8%)
-$10.37M(+3.9%)
Mar 2006
-
-$2.52M(-35.9%)
-$9.98M(+54.3%)
Dec 2005
-
-$3.93M(+2299.9%)
-$6.47M(+46.8%)
Sep 2005
-$6.84M(+148.7%)
-$163.90K(-95.1%)
-$4.41M(-25.6%)
Jun 2005
-
-$3.37M(-439.4%)
-$5.93M(+82.6%)
Mar 2005
-
$991.50K(-153.0%)
-$3.24M(-26.5%)
Dec 2004
-
-$1.87M(+11.1%)
-$4.41M(+60.5%)
Sep 2004
-$2.75M(+2787.3%)
-$1.68M(+145.8%)
-$2.75M(+186.9%)
Jun 2004
-
-$684.50K(+289.1%)
-$958.20K(+192.8%)
Mar 2004
-
-$175.90K(-14.6%)
-$327.20K(+27.8%)
Dec 2003
-
-$205.90K(-290.5%)
-$256.10K(+168.7%)
Sep 2003
-$95.20K(-61.3%)
$108.10K(-302.1%)
-$95.30K(-53.1%)
Jun 2003
-
-$53.50K(-49.0%)
-$203.40K(-14.5%)
Mar 2003
-
-$104.80K(+132.4%)
-$238.00K(+66.0%)
Dec 2002
-
-$45.10K(-48.8%)
-$143.40K(-11.2%)
Sep 2002
-$246.20K(+32.5%)
-
-
Jun 2002
-
-$88.10K(+763.7%)
-$161.50K(+52.4%)
Mar 2002
-
-$10.20K(-83.9%)
-$106.00K(-28.0%)
Dec 2001
-
-$63.20K(+93.9%)
-$147.20K(+63.6%)
Sep 2001
-$185.80K(+35.0%)
-
-
Jun 2001
-
-$32.60K(-36.6%)
-$90.00K(-21.7%)
Mar 2001
-
-$51.40K(+26.0%)
-$115.00K(-2.3%)
Dec 2000
-
-$40.80K(-217.2%)
-$117.70K(-14.5%)
Sep 2000
-$137.60K(-62.7%)
$34.80K(-160.4%)
-$137.60K(-8.7%)
Jun 2000
-
-$57.60K(+6.5%)
-$150.70K(-54.4%)
Mar 2000
-
-$54.10K(-10.9%)
-$330.70K(+13.2%)
Dec 1999
-
-$60.70K(-379.7%)
-$292.20K(+26.2%)
Sep 1999
-$368.50K(+614.1%)
$21.70K(-109.1%)
-$231.50K(-8.6%)
Jun 1999
-
-$237.60K(+1423.1%)
-$253.20K(+1523.1%)
Mar 1999
-
-$15.60K
-$15.60K
Sep 1998
-$51.60K(-94.0%)
-
-
Sep 1997
-$854.50K
-
-

FAQ

  • What is Arrowhead Pharmaceuticals, Inc. annual net profit?
  • What is the all time high annual net income for Arrowhead Pharmaceuticals, Inc.?
  • What is Arrowhead Pharmaceuticals, Inc. annual net income year-on-year change?
  • What is Arrowhead Pharmaceuticals, Inc. quarterly net profit?
  • What is the all time high quarterly net income for Arrowhead Pharmaceuticals, Inc.?
  • What is Arrowhead Pharmaceuticals, Inc. quarterly net income year-on-year change?
  • What is Arrowhead Pharmaceuticals, Inc. TTM net profit?
  • What is the all time high TTM net income for Arrowhead Pharmaceuticals, Inc.?
  • What is Arrowhead Pharmaceuticals, Inc. TTM net income year-on-year change?

What is Arrowhead Pharmaceuticals, Inc. annual net profit?

The current annual net income of ARWR is -$609.69M

What is the all time high annual net income for Arrowhead Pharmaceuticals, Inc.?

Arrowhead Pharmaceuticals, Inc. all-time high annual net profit is $67.97M

What is Arrowhead Pharmaceuticals, Inc. annual net income year-on-year change?

Over the past year, ARWR annual net profit has changed by -$400.42M (-191.34%)

What is Arrowhead Pharmaceuticals, Inc. quarterly net profit?

The current quarterly net income of ARWR is -$178.65M

What is the all time high quarterly net income for Arrowhead Pharmaceuticals, Inc.?

Arrowhead Pharmaceuticals, Inc. all-time high quarterly net profit is $367.86M

What is Arrowhead Pharmaceuticals, Inc. quarterly net income year-on-year change?

Over the past year, ARWR quarterly net profit has changed by -$4.67M (-2.69%)

What is Arrowhead Pharmaceuticals, Inc. TTM net profit?

The current TTM net income of ARWR is -$159.35M

What is the all time high TTM net income for Arrowhead Pharmaceuticals, Inc.?

Arrowhead Pharmaceuticals, Inc. all-time high TTM net profit is $67.97M

What is Arrowhead Pharmaceuticals, Inc. TTM net income year-on-year change?

Over the past year, ARWR TTM net profit has changed by +$388.01M (+70.89%)
On this page